Leukemia can increase the risk of blood clots, but the level of risk depends heavily on the specific type of leukemia you have. For most people with chronic leukemias, the risk is modest. For those with acute forms, especially acute promyelocytic leukemia (APL), the risk of dangerous clotting events is much higher and requires immediate medical attention. Understanding these differences is key to managing your health if you or someone you know has this diagnosis.
Does Leukemia Directly Cause Blood Clots?
Yes, but it is not a simple cause-and-effect. Leukemia does not make blood thicker in the way a clotting disorder might. Instead, the cancer changes how the body produces and behaves with blood cells.
Leukemia cells crowd the bone marrow. This leads to abnormal blood cell production. Some of these abnormal cells release substances that trigger clotting. Others make the blood more prone to sticking together. The immune system also reacts in ways that promote clot formation.
Research published in the journal Blood found that people with leukemia are about two to four times more likely to develop a blood clot compared to the general population. The risk is not the same for everyone. It depends on the leukemia subtype, treatment, and other personal factors.
What Are the Blood Clot Risks by Leukemia Type?
Different leukemias carry very different clot risks. Here is a breakdown by the main types.
| Leukemia Type | Clot Risk Level | Key Notes |
|---|---|---|
| Acute Promyelocytic Leukemia (APL) | Very high | Up to 10-20% of patients have clots at diagnosis. This is a medical emergency. |
| Acute Myeloid Leukemia (AML) without APL | Moderate to high | Risk increases with some chemotherapy drugs and central lines. |
| Acute Lymphoblastic Leukemia (ALL) | Moderate | Higher risk during treatment with steroids and certain chemotherapy. |
| Chronic Myeloid Leukemia (CML) | Low to moderate | Risk is lower, but some patients develop clots, especially with high white blood cell counts. |
| Chronic Lymphocytic Leukemia (CLL) | Low | Clot risk is similar to the general population unless treatment or other conditions are present. |
The highest risk by far is in APL. This rare subtype of AML causes a unique bleeding and clotting problem. Patients can have both dangerous clots and severe bleeding at the same time. Doctors treat this as a life-threatening emergency. If you have APL, your medical team will monitor you closely and use specific drugs to prevent and treat clots.
For other leukemias, the risk is real but lower. The clot risk often comes more from treatments than from the leukemia itself. Chemotherapy, steroids, and central venous catheters all increase clot risk.
How Does Leukemia Treatment Increase Clot Risk?
Treatment is a major factor. Some chemotherapy drugs damage the lining of blood vessels. This triggers the body to form clots. Steroids, often used in ALL and lymphoma treatment, increase the production of clotting factors in the liver.
Central lines, also called Port-a-Caths or PICC lines, are plastic tubes placed in large veins. They deliver chemotherapy and draw blood. But they also irritate the vein wall. This irritation is a common cause of deep vein thrombosis (DVT) in cancer patients. Studies show that up to 30% of cancer patients with central lines develop a clot in or near the line.
Some newer targeted therapies and immunotherapies also carry clot risks. For example, drugs like ponatinib used for CML have been linked to blood clots in some patients. Your doctor should discuss these risks before starting any new treatment.
What Are the Symptoms of a Blood Clot in Leukemia Patients?
Recognizing symptoms early can save your life. Blood clots can happen in veins or arteries. The most common location is a deep vein in the leg or arm.
Symptoms of a DVT include:
- Swelling in one leg or arm
- Pain or tenderness that feels like a cramp
- Warmth in the swollen area
- Red or discolored skin
A clot can break off and travel to the lungs. This is a pulmonary embolism (PE) and is life-threatening. Symptoms of a PE include:
- Sudden shortness of breath
- Sharp chest pain that gets worse with deep breaths
- Coughing up blood
- Fast heart rate or feeling lightheaded
If you have leukemia and develop any of these symptoms, seek emergency care immediately. Do not wait to see if it goes away. Blood clots in cancer patients can progress quickly.
Some people with leukemia also get clots in arteries. This can cause a stroke or heart attack. Symptoms include sudden weakness on one side of the body, trouble speaking, or sudden severe headache. Again, these are emergencies.
Can Blood Clots Be Prevented in Leukemia Patients?
Prevention is possible for many patients. The key is knowing your risk and acting early.
Doctors use blood thinners, also called anticoagulants, to prevent clots in high-risk patients. For APL, all patients receive preventive blood thinners as soon as the diagnosis is made. For other leukemias, doctors may prescribe blood thinners if you have additional risk factors like obesity, previous clots, or a central line.
Low molecular weight heparin, such as enoxaparin (Lovenox), is the most common preventive drug used in cancer patients. It is given as a shot under the skin. Direct oral anticoagulants (DOACs) like apixaban (Eliquis) or rivaroxaban (Xarelto) are also used, but doctors are more careful with them in leukemia patients because of the risk of bleeding.
Non-drug prevention matters too. Staying active when you can helps blood circulate. If you are in bed for long periods, ask about leg exercises or compression devices. Keep your legs elevated when sitting. Avoid crossing your legs for long periods. These small steps reduce the chance of blood pooling in your veins.
Your medical team should assess your clot risk regularly. If you have a central line, they should check the line site for signs of clot formation. Some hospitals use ultrasound to screen for clots in high-risk patients.
What Are Common Misconceptions About Leukemia and Blood Clots?
A common myth is that leukemia always causes blood clots. This is not true. Many people with chronic leukemias live for years without ever having a clot. The risk is real but not guaranteed.
Another misconception is that aspirin prevents clots in cancer patients. Aspirin is not recommended for clot prevention in leukemia. It does not work well enough against the type of clotting seen in cancer. More importantly, aspirin can increase bleeding risk, which is already a concern in leukemia patients with low platelet counts.
Some people believe that if they have no symptoms, they do not have a clot. This is dangerous. Many clots, especially in the leg, start with no symptoms at all. The first sign can be a pulmonary embolism. That is why prevention and screening are so important.
A third myth is that blood thinners are too dangerous for leukemia patients because of bleeding risk. It is true that leukemia patients have a higher risk of bleeding, especially if platelet counts are low. But in many cases, the risk of a fatal clot is higher than the risk of serious bleeding. Doctors carefully balance these risks. They monitor platelet counts and adjust blood thinner doses accordingly. Do not refuse a blood thinner without discussing it with your hematologist first.
Frequently Asked Questions
Does every leukemia patient need blood thinners?
No. Only patients with high-risk types like APL or those with additional clot risk factors typically receive preventive blood thinners. Your doctor will assess your individual risk.
Can leukemia treatment cause bleeding instead of clots?
Yes. Chemotherapy can lower platelet counts, which increases bleeding risk. Some patients experience both clotting and bleeding problems at different times during treatment.
How long does a leukemia patient stay on blood thinners?
It depends. Some patients take them only during active treatment. Others continue for several months after treatment ends. The duration is based on your ongoing clot risk.
Are blood clots in leukemia patients more dangerous than in other people?
Yes, they can be. Cancer-related clots are more likely to come back and harder to treat. They also increase the risk of dying from the cancer itself.
